Zurueck zur Suche

Reporte zur Charge FT8762

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

4Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
TN 2 CA 2

VAERS 2062837

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge FT8762

schwer
Staat
TN
Alter
20,0
Geschlecht
F
Eingang
25.01.2022
Impfdatum
10.12.2021
Beginn
17.12.2021
Tage bis Beginn
7,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Asthenia Balance disorder Blood iron increased Blood test Chest X-ray Chest pain Decreased appetite Disturbance in attention Dizziness Dyskinesia Electric shock sensation Electrocardiogram abnormal Fatigue Hypertension Hypoaesthesia Insomnia Muscle tightness Nausea

Symptomtext

Begining December 17, 2021: Shooting pain throughout body, felt like electricity coursing through the subcutaneous tissues; clawing of hand, rapid and painful involuntary contractions of hands; severe chest pains under clavicles and breasts; lateral shooting pains in femoral area; lumbar pain, jolts of electricity; tingling, numbness; fatigue, temporal headache; inability to sleep and concentrate; loss of appetite; dizzy; inbalaance at times; tightening of tibialis, gastrocnemius, and foot muscles; nausea; no energy

Weitere VAERSDATA-Felder
Praegender Schweregrund
Electric shock sensation
Hospital-Tage
-
Labordaten
EKG, complete blood workup, MRI and EMG are scheduled, neurological exam; chest xray and physical completed on 01-25-2022 by Dr; tested for anemia (neg.), tested for vitamin deficiencies (neg.), iron slightly elevated; EKG showed some tachycardia and higher BP than normal, Oxygen 96%
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 1981868

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge FT8762

mild
Staat
TN
Alter
52,0
Geschlecht
F
Eingang
27.12.2021
Impfdatum
09.12.2021
Beginn
10.12.2021
Tage bis Beginn
1,0
Dosis
2
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Blood test Influenza like illness Lymphadenopathy Pain Pyrexia

Symptomtext

Enlarged Lymph Node in the neck on the left side. I also had the expected flu-like symptoms with fever, body aches for about 72 hours following.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain
Hospital-Tage
-
Labordaten
Doctor visit, blood work.
Aktuelle Erkrankungen
No
Vorgeschichte
None
Andere Medikamente
Omeprazole, Saxenda
Allergien
Codeine
Vorherige Impfungen
-

VAERS 1978751

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge FT8762

mild
Staat
CA
Alter
45,0
Geschlecht
F
Eingang
24.12.2021
Impfdatum
01.12.2021
Beginn
01.12.2021
Tage bis Beginn
0,0
Dosis
3
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Hypersensitivity Immunisation Product administered at inappropriate site Pruritus Rash Skin discolouration Urticaria

Symptomtext

Booster; vaccine_location=Left leg; My leg developed a softball size welt; Discoloration; itching on my inner arms, upper chest and back that last about 10-20 minutes; Allergic reaction; Developing rashes (that look like little bubbles on my skin); itching about 2-3 days after I received the dose; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 45 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in leg left, administration date 01Dec2021 08:30 (Lot number: FT8762) at the age of 45 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Breast Cancer", start date: Nov2020 (unspecified if ongoing), notes: I had breast cancer in Nov2020 and radiation treatment 28Dec 2020 - 26Jan2021; "Known allergies: pineapple" (unspecified if ongoing), notes: Pineapple; "Known allergies: Sulfas" (unspecified if ongoing); "COVID-19" (unspecified if ongoing), notes: Prior to vaccination, was the patient diagnosed with COVID-19:Yes; "radiation treatment", start date: 28Dec2020, stop date: 26Jan2021, notes: radiation treatment 28Dec2020 - 26Jan2021. Concomitant medication(s) included: TAMOXIFEN; PROTONIX [OMEPRAZOLE]; MICARDIS; LEXAPRO. Past drug history included: Doxycycline, reaction(s): "Known allergies: Doxycicline". Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: EM9809, Location of injection: Arm Left, Vaccine Administration Time: 04:00 PM), administration date: 10Feb2021, when the patient was 44 years old, for COVID-19 immunization, reaction(s): "rashes", "allergic reaction", "Lymphedema", "itching on my inner arms, upper chest and back"; Bnt162b2 (Dose Number: 1, Batch/Lot No: EI9263, Location of injection: Arm Left, Vaccine Administration Time: 04:30 PM), administration date: 20Jan2021, when the patient was 44 years old, for COVID-19 immunization. The following information was reported: IMMUNISATION (non-serious) with onset 01Dec2021 08:30, outcome "unknown", described as "Booster"; PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (non-serious) with onset 01Dec2021 08:30, outcome "unknown", described as "vaccine_location=Left leg"; URTICARIA (non-serious) with onset Dec2021, outcome "not recovered", described as "My leg developed a softball size welt"; SKIN DISCOLOURATION (non-serious) with onset Dec2021, outcome "not recovered", described as "Discoloration"; PRURITUS (non-serious) with onset Dec2021, outcome "recovered" (Dec2021), described as "itching on my inner arms, upper chest and back that last about 10-20 minutes"; HYPERSENSITIVITY (non-serious) with onset Dec2021, outcome "not recovered", described as "Allergic reaction"; RASH (non-serious) with onset Dec2021, outcome "not recovered", described as "Developing rashes (that look like little bubbles on my skin)"; PRURITUS (non-serious) with onset Dec2021, outcome "not recovered", described as "itching about 2-3 days after I received the dose". The events "my leg developed a softball size welt", "discoloration", "itching on my inner arms, upper chest and back that last about 10-20 minutes", "allergic reaction", "developing rashes (that look like little bubbles on my skin)" and "itching about 2-3 days after i received the dose" were evaluated at the physician office visit. Therapeutic measures were taken as a result of urticaria, skin discolouration, pruritus, hypersensitivity, rash, pruritus. No follow-up attempts are possible. No further information is expected. Additional information : It was reported that patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received Tamoxifen, Protonix, Micardis, Lexapro, vitamins within 2 weeks of vaccination. Patients leg developed a softball size welt, discoloration and itching about 2-3 days after received the dose. On day 5, patient went to the urgent care and they said that he had an allergic reaction to the site. In addition, on day 7, patient started developing rashes (that look like little bubbles on my skin) and itching on my inner arms, upper chest and back that last about 10-20 minutes. The same thing happened after second dose and lasted about 2 months. Patient spoke to dermatologist and internist in the spring and both were confused. Now that it has started again after the booster, patient believed that there is a corelation.Treatment received for the adverse event with Benadryl and Tylenol. Patient has not been patient been tested for COVID-19 since vaccination. No prolonged hospitalization. Follow-up attempts are completed. No further information is expected..

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pruritus
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Breast cancer (I had breast cancer in Nov2020 and radiation treatment 28Dec 2020 - 26Jan2021); COVID-19 (Prior to vaccination, was the patient diagnosed with COVID-19:Yes); Drug allergy; Fruit allergy (Pineapple); Radiation therapy (radiation treatment 28Dec2020 - 26Jan2021)
Andere Medikamente
TAMOXIFEN; PROTONIX [OMEPRAZOLE]; MICARDIS; LEXAPRO
Allergien
-
Vorherige Impfungen
-

VAERS 1978748

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge FT8762

mild
Staat
CA
Alter
-
Geschlecht
F
Eingang
24.12.2021
Impfdatum
03.12.2021
Beginn
03.12.2021
Tage bis Beginn
0,0
Dosis
3
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Headache Immunisation Interchange of vaccine products Off label use Vaccination site pain Vaccination site pruritus Vaccination site reaction Vaccination site urticaria

Symptomtext

This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 48 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 03Dec2021 14:00 (Lot number: FT8762) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Moderna covid 19 vaccine (Dose:1, Anatomical location: left arm), administration date: 12Mar2021, when the patient was 47 years old, for COVID-19 immunization; Moderna covid 19 vaccine (Dose:2, Lot: 037A2113, Expiry: Unknown, Anatomical location: left arm), administration date: 09Apr2021, when the patient was 47 years old, for COVID-19 immunization. The following information was reported: OFF LABEL USE (non-serious), INTERCHANGE OF VACCINE PRODUCTS (non-serious) all with onset 03Dec2021 14:00, outcome "unknown" and all described as "received Moderna for her 1st 2 doses/received the Pfizer Covid 19 vaccine as her booster"; IMMUNISATION (non-serious) with onset 03Dec2021 14:00, outcome "unknown", described as "Booster"; VACCINATION SITE REACTION (non-serious) with onset 05Dec2021 19:30, outcome "recovered" (08Dec2021), described as "the 1st most significant adverse event was a significant reaction at the injection site on her left arm"; VACCINATION SITE URTICARIA (non-serious), VACCINATION SITE PAIN (non-serious), VACCINATION SITE PRURITUS (non-serious) all with onset 05Dec2021 19:30, outcome "recovered" (08Dec2021) and all described as "Significant hive at injection site that was raised, red, burning and itchy"; HEADACHE (non-serious) with onset 04Dec2021 09:00, outcome "recovered" (06Dec2021), described as "Headache". Therapeutic measures were taken as a result of vaccination site reaction, vaccination site urticaria, vaccination site pain, vaccination site pruritus, headache. Additional information: Patient's Medical History (including any illness at time of vaccination), AE(s) following prior vaccinations and Family Medical History Relevant to AE(s) was provided as None. AE(s) not require a visit to Emergency Room and Physician Office. Prior Vaccinations (within 4 weeks) If applicable, list any other vaccinations within four weeks prior to the first administration date of the suspect vaccine(s) was None. Patient stated that the 1st most significant adverse event was a significant reaction at the injection site on her left arm. She developed a large hive that spread over her entire deltoid region at the injection site, that was raised, red, burning, and itchy. She would say that it was severe. This developed around 7:30pm on 05Dec2021. Around 9am on 04Dec2021, she developed a moderately severe headache. She self treated at home for both events; no further details provided regarding treatment. These events occurred after she received the Pfizer Covid 19 vaccine as her booster. States that she received Moderna for her 1st 2 doses. This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Headache
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-